Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.

Abstract:

:Craniopharyngiomas and pituitary adenomas are both tumors of the hypothalamic and pituitary region, respectively that are frequently associated with endocrine defects either because of direct involvement of hormone producing cells (most pituitary tumors) or because of secondary defects due to disturbance of hypothalamic function (some pituitary tumors and craniopharyngiomas). Some studies suggest that mutant beta-catenin gene cells in craniopharyngiomas and pituitary adenomas contribute to their tumorigenesis. DNA was extracted from 73 cranial tumors and subjected to polymerase chain reaction (PCR) with previously described primers encompassing glycogen synthase kinase-3beta phosphorylation sites of the beta-catenin gene. Sequenced PCR products for possible beta-catenin gene mutations showed a total of 7/43 alterations in adamantinomatous craniopharyngioma-derived DNA samples. Two previously described beta-catenin mutations in codon 33 TCT(Ser) > TGT(Cys) and codon 37 TCT(Ser) > TTT(Phe), whereas three novel mutations in codon 41 ACC(Thr) > ATC(Ile), codon 33 TCT(Ser) > TAT(Tyr) and codon 32 GAC(Asp) > AAC(Asn) were observed. None of the 22 pituitary adenomas and the eight papillary craniopharyngiomas analyzed presented any sequence alterations. These findings demonstrate an association between beta-catenin gene alterations and craniopharyngiomas of the adamantinomatous type. Since this gene product is involved with development, these results suggest that beta-catenin mutations may contribute to the initiation and subsequent growth of congenital craniopharyngiomas.

journal_name

J Neurooncol

authors

Oikonomou E,Barreto DC,Soares B,De Marco L,Buchfelder M,Adams EF

doi

10.1007/s11060-004-5232-z

subject

Has Abstract

pub_date

2005-07-01 00:00:00

pages

205-9

issue

3

eissn

0167-594X

issn

1573-7373

journal_volume

73

pub_type

杂志文章
  • The effects of sequential treatments on hippocampal volumes in malignant glioma patients.

    abstract::Malignant gliomas (MG) are very aggressive tumors. In an effort to improve the outcome, the patients receive multi-modal therapies such as surgery, radiation and chemotherapy (temozolomide followed in many cases by bevacizumab). The survivors are affected by multiple learning and memory deficits. Greater deterioration...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-016-2188-8

    authors: Nolen SC,Lee B,Shantharam S,Yu HJ,Su L,Billimek J,Bota DA

    更新日期:2016-09-01 00:00:00

  • Early history of development of boron neutron capture therapy of tumors.

    abstract::The stable isotope 10B has a peculiarly marked avidity to capture slow neutrons whereupon it disintegrates into a lithium and a helium atom. These give up the 2.4 MeV of disintegration energy which they share within 5 and 9 microns of the 10B atom respectively. This means that the cell closest to the 10B atom bears th...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1023/a:1005752827194

    authors: Sweet WH

    更新日期:1997-05-01 00:00:00

  • High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot study.

    abstract::We conducted a phase II study to test methotrexate (5 g/m(2)), as a single agent prior to radiochemotherapy for pediatric high-grade glioma and diffuse intrinsic pontine glioma. Thirty patients (19 male, median age 10.8) were enrolled. Tumors were located as follows: cortex 10, pons 7, other 13. Tumor resection was cl...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s11060-010-0334-2

    authors: Wolff JE,Kortmann RD,Wolff B,Pietsch T,Peters O,Schmid HJ,Rutkowski S,Warmuth-Metz M,Kramm C

    更新日期:2011-05-01 00:00:00

  • Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.

    abstract::To evaluate diagnostic accuracy of perfusion weighted imaging (PWI) and positron emission tomography (PET) using an integrated PET/MR system in tumor grading as well as in differentiating recurrent tumor from treatment-induced effects (TIE) in brain tumor patients. Twenty patients (Group A: treatment naïve, 9 patients...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-015-2032-6

    authors: Sacconi B,Raad RA,Lee J,Fine H,Kondziolka D,Golfinos JG,Babb JS,Jain R

    更新日期:2016-04-01 00:00:00

  • Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

    abstract:PURPOSE:Although the survival of most melanoma patients diagnosed with leptomeningeal disease (LMD) is short, some patients can have better outcomes and prolonged survival. A large retrospective cohort of patients was analyzed to identify features associated with survival with LMD from melanoma. METHODS:Clinical chara...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-019-03121-2

    authors: Ferguson SD,Bindal S,Bassett RL Jr,Haydu LE,McCutcheon IE,Heimberger AB,Li J,O'Brien BJ,Guha-Thakurta N,Tetzlaff MT,Tawbi H,Davies MA,Glitza IC

    更新日期:2019-05-01 00:00:00

  • Neuroimaging classification of progression patterns in glioblastoma: a systematic review.

    abstract:BACKGROUND:Our primary objective was to report the current neuroimaging classification systems of spatial patterns of progression in glioblastoma. In addition, we aimed to report the terminology used to describe 'progression' and to assess the compliance with the Response Assessment in Neuro-Oncology (RANO) Criteria. ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-018-2843-3

    authors: Piper RJ,Senthil KK,Yan JL,Price SJ

    更新日期:2018-08-01 00:00:00

  • p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells.

    abstract::Increasing evidence suggests that an inflammatory microenvironment promotes invasion by glioblastoma (GBM) cells. Together with p38 mitogen-activated protein kinase (MAPK) activation being regarded as promoting inflammation, we hypothesized that elevated inflammatory cytokine secretion and p38 MAPK activity contribute...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-012-0875-7

    authors: Yeung YT,Bryce NS,Adams S,Braidy N,Konayagi M,McDonald KL,Teo C,Guillemin GJ,Grewal T,Munoz L

    更新日期:2012-08-01 00:00:00

  • A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors.

    abstract::The labeling index (LI) of 216 cases of human brain tumors was determined by the immunohistochemical technique with monoclonal antibody to bromodeoxyuridine (BrdU). The proliferative potential of 110 cases was estimated using the intra-operative intravenous infusion of BrdU at a dose of 200 mg/sq m. In another 106 cas...

    journal_title:Journal of neuro-oncology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF01059949

    authors: Kharbanda K,Dinda AK,Sarkar C,Karak AK,Dhir R,Mathur M,Roy S

    更新日期:1995-01-01 00:00:00

  • Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.

    abstract:INTRODUCTION:The standard treatment for primary central nervous system lymphoma (PCNSL) involves induction methotrexate-based chemotherapy with or without consolidation whole brain radiotherapy (WBRT). As WBRT carries a substantial risk for cognitive impairment, alternative consolidation treatments have been used to re...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-019-03257-1

    authors: Correa DD,Braun E,Kryza-Lacombe M,Ho KW,Reiner AS,Panageas KS,Yahalom J,Sauter CS,Abrey LE,DeAngelis LM,Omuro A

    更新日期:2019-09-01 00:00:00

  • Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.

    abstract::The leucine-rich repeats and immunoglobulin-like domains (LRIG) protein family is comprised of three integral membrane proteins: LRIG1, LRIG2, and LRIG3. LRIG1 is a negative regulator of growth factor signaling. The expression and subcellular localization of LRIG proteins have prognostic implications in primary brain ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-012-0856-x

    authors: Ghasimi S,Haapasalo H,Eray M,Korhonen K,Brännström T,Hedman H,Andersson U

    更新日期:2012-07-01 00:00:00

  • EMPACT syndrome: limited evidence despite a high-risk cohort.

    abstract::Serious dermatologic adverse events such as erythema multiforme (EM) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) have been reported in patients receiving antiepileptic drugs (AEDs) and cranial radiotherapy (RT). Given the frequency of AED-associated rashes and the infrequency of serious dermatolo...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-014-1457-7

    authors: Bishop AJ,Chang M,Lacouture ME,Barker CA

    更新日期:2014-08-01 00:00:00

  • Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

    abstract::Glioblastomas are malignant brain tumors with poor prognosis. Lately, data from clinical studies assessing the role of co-medications in different cancer types suggested reduced mortality and potential anti-tumor activity for statins, angiotensin-I converting enzyme inhibitors (ACEI) and angiotensin II receptor blocke...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s11060-018-2786-8

    authors: Happold C,Gorlia T,Nabors LB,Erridge SC,Reardon DA,Hicking C,Picard M,Stupp R,Weller M,EORTC Brain Tumor Group and on behalf of the CENTRIC and CORE Clinical Trial Groups.

    更新日期:2018-05-01 00:00:00

  • Neuropsychological sequelae of the treatment of children with medulloblastoma.

    abstract::When a malignant tumor invades the child's cerebellum, the cost of successful treatment is often significant cognitive morbidity. A review of neuropsychological outcome revealed that survivors of childhood medulloblastoma (MB) have long-term deficits in intelligence, memory, language, attention, academic skills, psych...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00165522

    authors: Dennis M,Spiegler BJ,Hetherington CR,Greenberg ML

    更新日期:1996-07-01 00:00:00

  • Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.

    abstract::The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions, this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here, we provide a framework for instituti...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-020-03488-7

    authors: Ramakrishna R,Zadeh G,Sheehan JP,Aghi MK

    更新日期:2020-05-01 00:00:00

  • MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.

    abstract::Accumulating evidence has supported the role of microRNAs in the initiation and development of malignant tumors. MicroRNA-211 (miR-211), which was reported to involve in diverse physiological activities in several cancers, was investigated for its expression in human glioma and adjacent normal brain tissues, as well a...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-017-2464-2

    authors: Zhang J,Lv J,Zhang F,Che H,Liao Q,Huang W,Li S,Li Y

    更新日期:2017-07-01 00:00:00

  • An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

    abstract::The treatment of visual pathway gliomas is controversial. The many retrospective studies reporting outcome data for patients with chiasmatic/hypothalamic gliomas are difficult to interpret for several reasons. First the natural history of these tumors is erratic with some reports suggesting that most visual pathway gl...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/BF00250197

    authors: Garvey M,Packer RJ

    更新日期:1996-05-01 00:00:00

  • Functioning oncocytic adenoma of the pituitary.

    abstract::A case of a functioning invasive pituitary oncocytoma in a 50-year-old man is reported. The serum prolactin was increased and immunocytochemical staining was positive for prolactin. In addition to numerous mitochondria within the neoplastic cells, structurally abnormal mitochondria with crystalline inclusions were als...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00165379

    authors: Chowdhury C,Roy S,Gupta N,Kochupillai N,Banerji AK

    更新日期:1986-01-01 00:00:00

  • Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

    abstract:PURPOSE:Because raised matrix metalloprotease (MMP) levels are associated with glioma invasion and angiogenesis, we tested the efficacy of marimastat (MT) an orally active drug that can reduce MMP levels, in patients with gliomas. PATIENTS AND METHODS:A total of 162 patients with intracranial glioblastoma multiforme o...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s11060-005-9098-5

    authors: Levin VA,Phuphanich S,Yung WK,Forsyth PA,Maestro RD,Perry JR,Fuller GN,Baillet M

    更新日期:2006-07-01 00:00:00

  • Evolving role of skullbase surgery for patients with low and high grade malignancies.

    abstract::Malignancy involving the skull base remains a formidable management challenge. Advances and refinements in diagnostic imaging, instrumentation, microvascular reconstruction, and an improved overall appreciation of the anatomy of the skullbase have extended the boundaries of tumor resectability and in some cases, obvia...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1023/b:neon.0000041882.41369.9b

    authors: DeMonte F

    更新日期:2004-08-01 00:00:00

  • miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.

    abstract::Meningiomas, one of the most common benign brain tumors in humans, arise from arachnoid cells in the brain meninges. Our investigations have revealed that miR-335 is a typical microRNA overexpressed in meningiomas in humans. Characterization of the effects of miR-335 overexpression in meningiomas demonstrated that ele...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-012-0951-z

    authors: Shi L,Jiang D,Sun G,Wan Y,Zhang S,Zeng Y,Pan T,Wang Z

    更新日期:2012-11-01 00:00:00

  • Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.

    abstract::In sporadic schwannomas, inactivation of both copies of the NF2 tumor suppressor gene on 22q is common. Constitutional mutations of SMARCB1 are responsible of schwannomatosis, an inherited tumor predisposition syndrome, characterized by the development of multiple schwannomas. We analysed the frequency of copy number ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-017-2711-6

    authors: Paganini I,Capone GL,Vitte J,Sestini R,Putignano AL,Giovannini M,Papi L

    更新日期:2018-03-01 00:00:00

  • Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers.

    abstract::Patients with metastatic well-differentiated thyroid cancer have a generally favorable long-term outcome although multi-organ involvement is a known marker of poor prognosis. Brain metastases are rare, occurring in less than 1% of patients with thyroid cancer. Few patients have been managed with stereotactic radiosurg...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s11060-010-0175-z

    authors: Bernad DM,Sperduto PW,Souhami L,Jensen AW,Roberge D

    更新日期:2010-06-01 00:00:00

  • "Comet tail sign": A pitfall of post-gadolinium magnetic resonance imaging findings for metastatic brain tumors.

    abstract::A highly enhanced cap attached to the surface of metastatic tumors in the brain parenchyma is occasionally encountered on magnetic resonance (MR) images. This atypical enhanced cap tends to occur in severe peritumoral edema and may produce the characteristic bulge of a metastatic mass lesion termed the "comet tail sig...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-016-2069-1

    authors: Mitsuya K,Nakasu Y,Narita Y,Nakasu S,Ohno M,Miyakita Y,Abe M,Ito I,Hayashi N,Endo M

    更新日期:2016-05-01 00:00:00

  • Impact of cognitive function on communication in patients with primary or secondary brain tumours.

    abstract::Communication support tools (CST) improve patient outcomes in oncology including: knowledge, satisfaction, self-management, and adherence to planned treatment. Little is known about communication support tools use in patients with primary or secondary brain tumours. We aimed to explore cognitive function and communica...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-015-1964-1

    authors: Naehrig DN,Koh ES,Vogiatzis M,Yanagisawa W,Kwong C,Shepherd HL,Milross C,Dhillon HM

    更新日期:2016-01-01 00:00:00

  • CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma.

    abstract::Cell differentiation agent-2 (CDA-2) is an extraction from healthy human urine consisting of primary organic acids and peptides, and it has been demonstrated to inhibit growth and induce differentiation in glioma and other cell lines. But the mechanism of CDA-2 remains unclear. In this study, we demonstrated that CDA-...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-012-0961-x

    authors: Xie YK,Huo SF,Zhang G,Zhang F,Lian ZP,Tang XL,Jin C

    更新日期:2012-11-01 00:00:00

  • Radiation therapy for incompletely resected supratentorial low-grade glioma in adults.

    abstract::In this review on current concepts in radiation therapy in the treatment of incompletely resected supratentorial low-grade glioma, a number of important issues are discussed. They include indication for radiation therapy, timing (early vs delayed), dose response issue, impact of modern neuroimaging, 'optimal' treatmen...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1023/a:1013333905202

    authors: Jeremic B,Bamberg M

    更新日期:2001-11-01 00:00:00

  • Multiple meningiomas: does quantity matter? a population-based survival analysis with underlined age and sex differences.

    abstract:INTRODUCTION:Intracranial meningiomas rarely present with multiple lesions. To the best of our knowledge, current literature regarding meningiomatosis (MM) is mostly comprised of small case series and individual reports. Hence, survival outcome data are limited. The Objective of this study is to explore the influence o...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-020-03620-7

    authors: Ramos-Fresnedo A,Domingo RA,Vivas-Buitrago T,Lundy L,Trifiletti DM,Jentoft ME,Desai AB,Quiñones-Hinojosa A

    更新日期:2020-09-01 00:00:00

  • Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.

    abstract::Ependymoma is the third most common brain tumor in children, but there is a paucity of large studies with more than 10 years of follow-up examining the long-term survival and recurrence patterns of this disease. We conducted a retrospective chart review of 103 pediatric patients with WHO Grades II/III intracranial epe...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s11060-017-2568-8

    authors: Marinoff AE,Ma C,Guo D,Snuderl M,Wright KD,Manley PE,Al-Sayegh H,Sinai CE,Ullrich NJ,Marcus K,Haas-Kogan D,Goumnerova L,London WB,Kieran MW,Chi SN,Fangusaro J,Bandopadhayay P

    更新日期:2017-10-01 00:00:00

  • Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.

    abstract::Patients with metastatic disease are living longer and may be confronted with locally or regionally recurrent brain metastases (BM) after prior stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSRT). This study analyzes outcomes in patients without prior whole brain radiotherapy (WBRT) who we...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-013-1191-6

    authors: Kim DH,Schultheiss TE,Radany EH,Badie B,Pezner RD

    更新日期:2013-10-01 00:00:00

  • Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.

    abstract:PURPOSE:Glioblastoma (GBM) is the most aggressive adult brain cancer, with a 15 month median survivorship attributed to the existence of treatment-refractory brain tumor initiating cells (BTICs). In order to better understand the mechanisms regulating the tumorigenic properties of this population, we studied the role o...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-019-03192-1

    authors: Vora P,Seyfrid M,Venugopal C,Qazi MA,Salim S,Isserlin R,Subapanditha M,O'Farrell E,Mahendram S,Singh M,Bakhshinyan D,Chokshi C,McFarlane N,Dvorkin-Gheva A,Brown KR,Murty N,Moffat J,Bader GD,Singh SK

    更新日期:2019-07-01 00:00:00